欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号SE/H/2051/001
药品名称Linagliptin STADA
活性成分
    • linagliptin 5.0 mg
剂型Film-coated tablet
上市许可持有人Stada Arzneimittel AG, Germany
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • Portugal (PT)
    • Italy (IT)
    • Finland (FI)
    • Hungary (HU)
    • Czechia (CZ)
      Linagliptin STADA
    • Denmark (DK)
    • Slovakia (SK)
      Linagliptin STADA 5 mg filmom obalené tablety
    • Belgium (BE)
      Linagliptin EG 5 mg filmomhulde tabletten
    • Slovenia (SI)
    • Luxembourg (LU)
    • Iceland (IS)
      Linagliptin STADA
    • Ireland (IE)
    • Austria (AT)
    • Spain (ES)
许可日期2021/04/21
最近更新日期2024/10/24
药物ATC编码
    • A10BH05 linagliptin
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Multiple (Copy) Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase